Next‐generation sequencing of residual cytologic fixative preserved DNA from pancreatic lesions: A pilot study
暂无分享,去创建一个
R. Yantiss | M. Pittman | A. Borczuk | J. Mosquera | J. Heymann | C. Sigel | R. Rao | E. Hissong | M. Siddiqui | Wei Song | H. Fernandes | Kyung Park | S. Mirabelli | Mai Ho | Susan A. Alperstein | Thomas L. Dilcher | Clifton G. Fulmer
[1] A. Gavin,et al. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study. , 2019, The Lancet. Oncology.
[2] Anas M. Saad,et al. Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study , 2018, BMC Cancer.
[3] I. Wistuba,et al. Salvaging the supernatant: next generation cytopathology for solid tumor mutation profiling , 2018, Modern Pathology.
[4] M. Goggins,et al. Pancreatic Juice Mutation Concentrations Can Help Predict the Grade of Dysplasia in Patients Undergoing Pancreatic Surveillance , 2018, Clinical Cancer Research.
[5] M. Eccles,et al. A streamlined method for analysing genome-wide DNA methylation patterns from low amounts of FFPE DNA , 2017, BMC Medical Genomics.
[6] R. Olsen,et al. Next-Generation Sequencing Identifies Gene Mutations That Are Predictive of Malignancy in Residual Needle Rinses Collected From Fine-Needle Aspirations of Thyroid Nodules. , 2017, Archives of pathology & laboratory medicine.
[7] Donavan T. Cheng,et al. Mutational Landscape of Metastatic Cancer Revealed from Prospective Clinical Sequencing of 10,000 Patients , 2017, Nature Medicine.
[8] N. Mishra,et al. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer , 2017, Oncotarget.
[9] R. Klein,et al. Next‐generation sequencing of liquid‐based cytology non–small cell lung cancer samples , 2017, Cancer cytopathology.
[10] J. Kleeff,et al. Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): Identification of prognostic subtypes , 2017, Scientific Reports.
[11] A. Iafrate,et al. Next‐generation sequencing adds value to the preoperative diagnosis of pancreatic cysts , 2017, Cancer cytopathology.
[12] F. Abdul-Karim,et al. Interobserver agreement in the cytologic grading of atypia in neoplastic pancreatic mucinous cysts with the 2‐tiered approach , 2016, Cancer cytopathology.
[13] J. K. Lee,et al. The Combination of Cyst Fluid Carcinoembryonic Antigen, Cytology and Viscosity Increases the Diagnostic Accuracy of Mucinous Pancreatic Cysts , 2016, Gut and liver.
[14] Shuanzeng Wei,et al. Using “residual” FNA rinse and body fluid specimens for next‐generation sequencing: An institutional experience , 2016, Cancer cytopathology.
[15] I A McNeish,et al. Methanol-based fixation is superior to buffered formalin for next-generation sequencing of DNA from clinical cancer samples , 2015, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] Jin-Young Jang,et al. A combination of molecular markers and clinical features improve the classification of pancreatic cysts. , 2015, Gastroenterology.
[17] Donavan T. Cheng,et al. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology. , 2015, The Journal of molecular diagnostics : JMD.
[18] Jianmin Wu,et al. Genome‐wide DNA methylation patterns in pancreatic ductal adenocarcinoma reveal epigenetic deregulation of SLIT‐ROBO, ITGA2 and MET signaling , 2014, International journal of cancer.
[19] Mari Mino-Kenudson,et al. Cytological criteria of high‐grade epithelial atypia in the cyst fluid of pancreatic intraductal papillary mucinous neoplasms , 2014, Cancer cytopathology.
[20] M. Mino‐Kenudson,et al. Grading epithelial atypia in endoscopic ultrasound‐guided fine‐needle aspiration of intraductal papillary mucinous neoplasms: An international interobserver concordance study , 2013, Cancer cytopathology.
[21] Faris M. Murad,et al. Rapid on‐site evaluation for endoscopic ultrasound‐guided fine‐needle biopsy of the pancreas decreases the incidence of repeat biopsy procedures , 2013, Cancer cytopathology.
[22] T. Bonfiglio,et al. False‐negative rate of endoscopic ultrasound‐guided fine‐needle aspiration for pancreatic solid and cystic lesions with matched surgical resections as the gold standard , 2013, Cancer cytopathology.
[23] R. Wolff,et al. Use of EUS-FNA in diagnosing pancreatic neoplasm without a definitive mass on CT. , 2013, Gastrointestinal endoscopy.
[24] A. Krasinskas,et al. Integration of KRAS testing in the diagnosis of pancreatic cystic lesions: a clinical experience of 618 pancreatic cysts , 2013, Modern Pathology.
[25] Patricia M. Agreda,et al. Long-Term Stability of Human Genomic and Human Papillomavirus DNA Stored in BD SurePath and Hologic PreservCyt Liquid-Based Cytology Media , 2013, Journal of Clinical Microbiology.
[26] B. Amanuel,et al. Optimizing the multimodal approach to pancreatic cyst fluid diagnosis , 2013, Cancer cytopathology.
[27] M. Eloubeidi,et al. How Good Is Endoscopic Ultrasound–Guided Fine-Needle Aspiration in Diagnosing the Correct Etiology for a Solid Pancreatic Mass?: A Meta-Analysis and Systematic Review , 2013, Pancreas.
[28] Y. Yatabe,et al. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses. , 2012, Gastrointestinal endoscopy.
[29] M. Nikiforova,et al. EUS-FNA Mutational Analysis in Differentiating Autoimmune Pancreatitis and Pancreatic Cancer , 2011, Pancreatology.
[30] Pierre Michel,et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. , 2011, The New England journal of medicine.
[31] Michael A. Choti,et al. DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.
[32] R. Hawes,et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. , 2009, Gastrointestinal endoscopy.
[33] C. Mian,et al. Human papillomavirus typing with hybrid capture II on archived liquid-based cytologic specimens: is HPV typing always reproducible? , 2004, American journal of clinical pathology.
[34] Diane Solomon,et al. Stability of archived liquid‐based cervical cytologic specimens , 2003, Cancer.
[35] D. Klimstra,et al. Long-term survival after curative resection for pancreatic ductal adenocarcinoma. Clinicopathologic analysis of 5-year survivors. , 1996, Annals of surgery.
[36] Toshiya Takeda,et al. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging , 1993, Cancer.
[37] Mithat Gönen,et al. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma , 2017, Annals of surgery.
[38] AACR Project GENIE: Powering Precision Medicine through an International Consortium. , 2017, Cancer discovery.
[39] Thomas O. McDonald,et al. Next-Generation Sequencing and Fluorescence in Situ Hybridization Have Comparable Performance Characteristics in the Analysis of Pancreaticobiliary Brushings for Malignancy. , 2016, The Journal of molecular diagnostics : JMD.
[40] A. Iafrate,et al. Impact of next-generation sequencing on the clinical diagnosis of pancreatic cysts. , 2016, Gastrointestinal endoscopy.